Role of Interleukin-18 in Modulation of Oral Carcinoma Cell Proliferation

<p>Interleukin-18 (IL-18), a proinflammatory cytokine, is produced by oral epithelia and carcinoma cells and implicated in tumor regression. Since its direct biological effect on oral cancer cells is not well defined, in this study, we employed a KB cell line to test IL-18 activity. Recombinan...

Full description

Saved in:
Bibliographic Details
Format: Article
Language:English
Published: Wiley 2006-01-01
Series:Mediators of Inflammation
Online Access:http://www.hindawi.com/GetArticle.aspx?doi=10.1155/MI/2006/67120
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562895412527104
collection DOAJ
description <p>Interleukin-18 (IL-18), a proinflammatory cytokine, is produced by oral epithelia and carcinoma cells and implicated in tumor regression. Since its direct biological effect on oral cancer cells is not well defined, in this study, we employed a KB cell line to test IL-18 activity. Recombinant human IL-18 significantly inhibited KB cell proliferation in a dose-dependent fashion (<mml:math><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x003C;</mml:mo><mml:mn>.05</mml:mn></mml:mrow></mml:math>) without increasing cytotoxicity. Analysis of its mode of action showed that IL-18 induced cell cycle arrest in the S phase; however, it did not trigger apoptotic cell death. Findings in this study indicate that the suppression of KB cell proliferation was attributed to the modulation of cell cycle progression, providing a new role of this cytokine in antitumor mechanisms. </p>
format Article
id doaj-art-a20478668f6342f285e4db9667fc0e57
institution Kabale University
issn 0962-9351
language English
publishDate 2006-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-a20478668f6342f285e4db9667fc0e572025-02-03T01:21:31ZengWileyMediators of Inflammation0962-93512006-01-012006Role of Interleukin-18 in Modulation of Oral Carcinoma Cell Proliferation<p>Interleukin-18 (IL-18), a proinflammatory cytokine, is produced by oral epithelia and carcinoma cells and implicated in tumor regression. Since its direct biological effect on oral cancer cells is not well defined, in this study, we employed a KB cell line to test IL-18 activity. Recombinant human IL-18 significantly inhibited KB cell proliferation in a dose-dependent fashion (<mml:math><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x003C;</mml:mo><mml:mn>.05</mml:mn></mml:mrow></mml:math>) without increasing cytotoxicity. Analysis of its mode of action showed that IL-18 induced cell cycle arrest in the S phase; however, it did not trigger apoptotic cell death. Findings in this study indicate that the suppression of KB cell proliferation was attributed to the modulation of cell cycle progression, providing a new role of this cytokine in antitumor mechanisms. </p>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/MI/2006/67120
spellingShingle Role of Interleukin-18 in Modulation of Oral Carcinoma Cell Proliferation
Mediators of Inflammation
title Role of Interleukin-18 in Modulation of Oral Carcinoma Cell Proliferation
title_full Role of Interleukin-18 in Modulation of Oral Carcinoma Cell Proliferation
title_fullStr Role of Interleukin-18 in Modulation of Oral Carcinoma Cell Proliferation
title_full_unstemmed Role of Interleukin-18 in Modulation of Oral Carcinoma Cell Proliferation
title_short Role of Interleukin-18 in Modulation of Oral Carcinoma Cell Proliferation
title_sort role of interleukin 18 in modulation of oral carcinoma cell proliferation
url http://www.hindawi.com/GetArticle.aspx?doi=10.1155/MI/2006/67120